Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid

The effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway

(2015) Yohji Honda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib

(2014) Tomokazu Kawaoka et al.   HEPATOLOGY RESEARCH

Skeletal-related Events and Clinical Outcomes in Patients with Bone Metastases and Normal Levels of Osteolysis: Exploratory Analyses

(2012) A. Lipton et al.   CLINICAL ONCOLOGY

Hepatocellular carcinoma with extrahepatic metastasis

(2011) Koji Uchino et al.   CANCER

Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases

(2011) E. Chow et al.   CLINICAL ONCOLOGY

Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma

(2010) Yoshio Katamura et al.   HEPATOLOGY RESEARCH

Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan

(2010) Masahito Nakano et al.   HEPATOLOGY RESEARCH

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)

(2010) Shigeki Arii et al.   HEPATOLOGY RESEARCH

Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity

(2008) Vera Hirsh et al.   Journal of Thoracic Oncology

Combination Therapy of Oral Fluoropyrimidine Anticancer Drug S-1 and Interferon Alpha for HCC Patients with Extrahepatic Metastases

(2008) Kiminori Uka et al.   ONCOLOGY